利用癌细胞中的信号重新连接与同时存在的致癌驱动因素
Roberto Chiarle1,2, Chiara Ambrogio2
1Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
Molecular oncology
|October 24, 2023
概括
向癌症疗法抑制驱动性瘤基因为研究瘤进化提供了新的途径. 了解癌症如何适应这些治疗是开发更有效,个性化的癌症药物的关键.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 分子生物学分子生物学
背景情况:
- 针对特定驱动性瘤基因的向疗法正在彻底改变癌症治疗.
- 选择性抑制剂为癌症研究提供了新的实验和临床方法.
研究的目的:
- 利用向疗法探索癌症发展和治疗反应的动态.
- 研究癌细胞如何在受抑制剂的选择性压力下适应和进化.
主要方法:
- 利用选择性抑制剂在体外和体内向关键驱动性瘤基因.
- 进行纵向和克隆进化研究,追踪癌细胞的适应.
主要成果:
- 直接抑制驱动性瘤基因允许详细观察癌细胞适应.
- 癌细胞在对治疗的反应中表现出信号依赖性的重新连接和利用.
结论:
- 向疗法提供了一个独特的机会,可以实时研究癌症的演变.
- 解决治疗适应性的挑战对于推进个性化癌症疗法至关重要.
相关概念视频
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Canonical Wnt Signaling Pathway
8.8K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K


